Position in VTRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$51,920,453
+$5,891,573 QoQ
Shares Held
3,269,550
-4.0% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 1,016 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,988,618 | $286,622,087 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
219,094 | $118,711,701 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,929,853 | $65,383,418 | |
| 4 | VTRS |
Viatris Inc
This page
|
3,269,550 | $51,920,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
220,463 | $37,156,833 | |
| 6 | ALKS |
Alkermes plc.
|
217,739 | $11,409,523 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
82,089 | $9,106,952 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
31,793 | $2,631,824 |
All Filings in VTRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,920,453 | 3,269,550 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $46,028,880 | 3,407,023 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $22,769,878 | 1,828,906 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,147,987 | 3,752,322 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $78,435,974 | 8,783,424 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $44,372,113 | 5,094,388 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $111,932,891 | 8,990,594 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $91,272,681 | 7,861,558 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $83,530,642 | 7,858,010 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $105,968,280 | 8,875,066 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $78,387,469 | 7,237,994 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $67,186,477 | 6,814,045 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,434,813 | 2,849,180 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $72,026,744 | 7,487,188 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $125,948,300 | 11,316,110 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $96,757,692 | 11,356,537 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,933,919 | 1,521,865 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $10,541,301 | 968,870 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $22,263,175 | 1,645,468 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,766,545 | 1,680,188 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||